Redburn Partners analyst Russell Quelch initiates coverage on Verisk Analytics (NASDAQ:VRSK) with a Sell rating.
Expert Ratings for 2seventy bio
Analysts have provided the following ratings for 2seventy bio (NASDAQ:TSVT) within the last quarter: Bullish Somewhat Bullish Indifferent…